Predictive value of vaginal lactic acid bacteria changes on occurrence of HR-HPV-infected cervical intraepithelial neoplasia and construction and validation of nomogram model
- PMID: 40707911
- PMCID: PMC12291497
- DOI: 10.1186/s12885-025-14604-z
Predictive value of vaginal lactic acid bacteria changes on occurrence of HR-HPV-infected cervical intraepithelial neoplasia and construction and validation of nomogram model
Abstract
Objective: To explore the predictive value of vaginal lactic acid bacteria changes on the occurrence of HR-HPV infected cervical intraepithelial neoplasia (CIN), and to construct and validate Nomogram model.
Methods: The community composition, quantitative distribution and other indicators of vaginal lactic acid bacteria in patients with and without CIN were detected and analyzed. The key lactic acid bacteria characteristics and other potential risk factors related to CIN were screened out using statistical methods, and then the Nomogram prediction model was constructed. The model discrimination was assessed by the receiver operating characteristic (ROC) and the calibration curves, and decision curves analysis (DCA) was performed to verify the reliability of the model.
Results: There was no significant difference in the incidence of CIN, baseline data and vaginal lactic acid bacteria parameters between the training set and the verification set (P > 0.05). Univariate analysis identified significant differences in clinical factors (e.g., age of first sexual activity, safety measures) and vaginal lactobacilli (e.g., L. acidophilus, L. jenseni, L. gasseri, L. rhamnosus) between groups (P < 0.05). Multivariate Logistic regression confirmed safety measures, serum progesterone levels, and relative abundances of L. acidophilus, L. crispatus, L. jenseni, and L. rhamnosus as independent risk factors for CIN (P < 0.05). Further, the nomogram prediction model was constructed, and the nomogram model had good calibration and fit between prediction and reality in the training set and the verification set, and the nomogram demonstrated excellent discrimination in the training set and validation set, with calibration curves showing minimal absolute error (0.048 vs. 0.046) and DCA confirming clinical utility across a threshold probability of 0.05-0.95.
Conclusion: Changes in vaginal lactobacilli (e.g., reduced L. acidophilus, L. jenseni, L. gasseri, and L. rhamnosus) are significantly associated with CIN risk, potentially reflecting dysbiosis-driven vulnerability to HR-HPV persistence The Nomogram model demonstrated high accuracy in internal validation, suggesting its potential utility as a clinician-friendly tool for individualized risk assessment. However, external validation in prospective cohorts is required before clinical implementation.
Keywords: Cervical intraepithelial neoplasia; HR-HPV infection; Nomogram model; Vaginal lactic acid bacteria.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was approved by the Ethics Committee of The Ninth Medical Center of PLA General Hospital (No. 2021–031532), and informed consent was obtained from all patients. This study was conducted in accordance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Comprehensive cross-sectional study of CIN prevalence, HPV genotyping, genetic alterations, and microbiota as molecular biomarkers for early cervical cancer detection: A pilot clinical study among women in Russia.Int J Gynaecol Obstet. 2025 Aug;170(2):916-926. doi: 10.1002/ijgo.70090. Epub 2025 May 5. Int J Gynaecol Obstet. 2025. PMID: 40323698
-
Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.Int J Gynecol Cancer. 2010 Aug;20(6):1067-73. doi: 10.1111/IGC.0b013e3181e4a720. Int J Gynecol Cancer. 2010. PMID: 20683419
-
Cytology versus HPV testing for cervical cancer screening in the general population.Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2. Cochrane Database Syst Rev. 2017. PMID: 28796882 Free PMC article.
-
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33. Epidemiol Prev. 2012. PMID: 23139163 Italian.
-
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7. Gynecol Obstet Invest. 2025. PMID: 39374596 Free PMC article.